Ikaros is markedly sumoylated in human B-ALL cells, and sumoylation occurs at three conserved lysine residues that act as SUMO1 and/or SUMO2,3 acceptor sites. This evidence concerns the gene SUMO2 and precursor B-cell acute lymphoblastic leukemia.